PMID- 35231655 OWN - NLM STAT- MEDLINE DCOM- 20220411 LR - 20220411 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 601 DP - 2022 Apr 23 TI - Transcriptome analysis of long non-coding RNAs reveals NR_015556 lncRNA is a novel regulator for adipocyte differentiation. PG - 79-85 LID - S0006-291X(22)00259-5 [pii] LID - 10.1016/j.bbrc.2022.02.069 [doi] AB - Long non-coding RNAs (lncRNAs) have gained extensive attentions due to their significant roles in diverse biological process. However, the potential functions of lncRNAs participation in adipocyte differentiation have not been fully explored. In the present study, we globally profiled lncRNA expression using lncRNA microarray and identified 1745 lncRNA probes with differential expression on day 0 and day 4 post-induction in both C3H10T1/2 mesenchymal stem cells and 3T3-L1 preadipocytes. Furthermore, we showed that stable shRNA knockdown (KD) of NR_015556, a novel lncRNA that was significantly down-regulated in adipocyte differentiation, promoted adipocyte differentiation by increasing the number of lipid droplets and adipocyte markers such as Fabp4, Adipsin and Fasn. Mechanistically, NR_015556 KD attenuated the expression of Wnt signaling components Wnt10b and non-phospho (active) beta-catenin, and elevated adipocyte master factors Ppar-gamma and C/EBPalpha levels. Conversely, pharmacological activation of Wnt10b-beta-catenin signaling by LiCl suppressed NR_015556 KD-induced enhancement of adipocyte differentiation and Ppar-gamma and C/EBPalpha expression levels. Taken together, these results indicate that down-regulation of NR_015556 promotes adipocyte differentiation through inhibiting Wnt10b-beta-catenin signaling pathway and then elevating Ppar-gamma and C/EBPalpha triggered transcriptional cascades. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Zuo, Changqing AU - Zuo C AD - Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, And School of Pharmacy, Guangdong Medical University, Dongguan, 523808, PR China; Key Laboratory of Traditional Chinese Medicine and New Pharmacy Development, Guangdong Medical University, Dongguan, 523808, PR China. FAU - Pan, Yaqiong AU - Pan Y AD - Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, And School of Pharmacy, Guangdong Medical University, Dongguan, 523808, PR China; Department of Pharmacy, Dongguan Liaobu Hospital, Guangdong Medical University, Dongguan, 523400, PR China. FAU - Leng, Dan AU - Leng D AD - Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, And School of Pharmacy, Guangdong Medical University, Dongguan, 523808, PR China. FAU - Chen, Xiuju AU - Chen X AD - Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, And School of Pharmacy, Guangdong Medical University, Dongguan, 523808, PR China. FAU - Dong, Fanghongniu AU - Dong F AD - Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, And School of Pharmacy, Guangdong Medical University, Dongguan, 523808, PR China. FAU - Lin, Zhanying AU - Lin Z AD - Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, And School of Pharmacy, Guangdong Medical University, Dongguan, 523808, PR China. FAU - Dai, Zhong AU - Dai Z AD - Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, And School of Pharmacy, Guangdong Medical University, Dongguan, 523808, PR China; Key Laboratory of Traditional Chinese Medicine and New Pharmacy Development, Guangdong Medical University, Dongguan, 523808, PR China. Electronic address: daizhong_gdmu@163.com. FAU - Wang, Zonggui AU - Wang Z AD - Department of Biochemistry and Molecular Biology, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, 523808, PR China. Electronic address: wangzonggui@gdmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220222 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (CCAAT-Enhancer-Binding Protein-alpha) RN - 0 (PPAR gamma) RN - 0 (RNA, Long Noncoding) RN - 0 (beta Catenin) SB - IM MH - 3T3-L1 Cells MH - Adipocytes/metabolism MH - Adipogenesis/genetics MH - Animals MH - CCAAT-Enhancer-Binding Protein-alpha/genetics MH - Cell Differentiation/genetics MH - Gene Expression Profiling MH - Mice MH - PPAR gamma/metabolism MH - *RNA, Long Noncoding/genetics/metabolism MH - Wnt Signaling Pathway/genetics MH - beta Catenin/genetics/metabolism OTO - NOTNLM OT - Adipocyte differentiation OT - NR_015556 OT - Wnt10b OT - beta-catenin COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2022/03/02 06:00 MHDA- 2022/04/12 06:00 CRDT- 2022/03/01 20:13 PHST- 2022/01/12 00:00 [received] PHST- 2022/02/18 00:00 [accepted] PHST- 2022/03/02 06:00 [pubmed] PHST- 2022/04/12 06:00 [medline] PHST- 2022/03/01 20:13 [entrez] AID - S0006-291X(22)00259-5 [pii] AID - 10.1016/j.bbrc.2022.02.069 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2022 Apr 23;601:79-85. doi: 10.1016/j.bbrc.2022.02.069. Epub 2022 Feb 22.